BSI-201 Demonstrates Significant Tumor Growth Inhibition In Ovarian Cancer Studies
BiPar Sciences announced positive preclinical data demonstrating the activity of its lead poly ADP-ribose polymerase (PARP) inhibitor, BSI-201, in ovarian cancer models.
|
Diagnostic Tests Identify Ovarian Cancer Progression, Apoptosis
The FAS-detect IHC test was used in evaluating 321 samples of serous ovarian cancer.
|
BioNumerik Commences Ovarian Cancer Trial On Karenitecin
BioNumerik Pharmaceuticals initiates global Phase III clinical trial of BioNumerik's anticancer drug candidate known as Karenitecin in advanced ovarian cancer patients.
|
Northwest Biotherapeutics Conducts Ovarian Cancer Clinical Trial
Northwest Biotherapeuticsannounced that a Phase I/II clinical trial in at least 30 patients, using DCVax-L for recurrent ovarian cancer, has begun
|
Link Between Cell Survival Proteins, Ovarian Cancer Aggressiveness
Scientific team has found that the elevated levels of certain proteins typically associated with keeping cancer cells alive may actually correspond with improved patient survival in ovarian cancer.
|
Eating Flavonoid-Rich Diet Helps Women Decrease Risk Of Ovarian Cancer
Frequent consumption of foods containing the flavonoid kaempferol, including non-herbal tea and broccoli, was associated with a reduced risk of ovarian cancer.
|
Biomarkers Help Detect Early-Stage Ovarian Cancer
Vermillion presented data demonstrating that several of Vermillion's ovarian cancer protein biomarkers could be used to detect early-stage ovarian cancer and to predict survival.
|
Possible New Treatment for Patients with Platinum-Resistant Ovarian Cancer
Phase 2 Consortium clinical trial shows promising results for ovarian cancer treatment in platinum-resistant ovarian cancer patients.
|
Mutation of the COX2 gene can double or treble a woman's risk of ovarian cancer
Researchers have discovered that a specific mutation of the COX2 gene seems to play a role in the onset of ovarian cancer, increasing women's susceptibility to developing ovarian cancer.
|
Ovarian Cancer: Not-So-Silent Killer
First, researchers recently reported a cluster of symptoms that can indicate ovarian cancer.
|
Angiolix Is Effective In Ovarian And Breast Cancer
Access Pharmaceuticals, Somanta Pharmaceuticals announced new data emerging from a pre-clinical collaboration with Imperial College London suggests that Somanta's Angiolix could be effective in the treatment of ovarian cancer.
|
One-Third Of Canadian Women Believe HPV Vaccines Prevent Ovarian Cancer
More than one-third of Canadian women believe that human papillomavirus vaccines prevent ovarian cancer.
|
Cranberries may improve chemotherapy for ovarian cancer
Compounds in cranberries may help improve the effectiveness of platinum drugs that are used in chemotherapy to fight ovarian cancer.
|
Advancements In Early Diagnosis Of Ovarian Cancer May 'Lay' With Chickens
Scientists may have discovered the perfect model for potentially developing early detection of ovarian cancer; the chicken.
|
Transvaginal Ultrasounds, Blood Tests Effective In Screening For Ovarian Cancer
Studies show encouraging results in detecting early-stage ovarian cancer in high-risk groups of women.
|
Real Value' Of Ovarian Cancer Recommendations Might Be Increased Awareness
The "real value" of recommendations released last week for identifying symptoms that could signal early stages of ovarian cancer might be to "raise awareness" of the disease among physicians and their patients.
|
Ovarian Cancer Surgeon Echoes Recent American Cancer Society Findings
Ovarian Cancer Institute in Atlanta echoes findings in a report issued from the American Cancer Society, Gynecologic Cancer Foundation and the Society of Gynecologic Oncologists.
|
First National Consensus On Ovarian Cancer Symptoms
National Ovarian Cancer Coalition joins the Gynecologic Cancer Foundation and other national organizations in announcing the first national agreement on ovarian cancer symptoms.
|
PET/CT - Test For Women With Ovarian Cancer
An advanced molecular imaging technique influenced the management of women with ovarian cancer, detected more sites of disease and identified women whose disease was likely to progress.
|
Protein Biomarkers Useful For Diagnosis Of Early-Stage Ovarian Cancer
Ciphergen Biosystems Inc. presented data on the discovery of several protein biomarkers that may be potential diagnostic markers in detection of early-stage ovarian cancer.
|
Study Pries Into Ovarian Cancer's Deadly Secrets
Study sheds light on cell defects that lead to one common type of ovarian cancer and puts forth a promising new mouse model that already is being used for preclinical drug testing.
|
Many women undertreated for ovarian cancer
One in three ovarian cancer patients in the U.S. fails to receive the recommended comprehensive surgical treatment
|
Expert centers prove cost-effective in managing ovarian cancer
The medical professional that manages the ovarian cancer patient impacts the quality.
|
Researchers Identify Ovarian Cancer Biomarkers
The finding, while preliminary, could one day improve screening, diagnosis and treatment for this disease.
|
Ovarian Cancer May Mimic Fallopian Tube Formation
A new study suggests that ovarian cancer cells form by hijacking a developmental genetic process normally used to form fallopian tubes.
|
'Clumping' protein linked to return of ovarian cancer
Women treated for ovarian cancer are at increased risk of a rapid and potentially fatal recurrence if their tumor cells have high levels of a binding protein that triggers abnormal growth.
|
Symptom Screening Advances Early Ovarian Cancer Detection
Evidence suggests that early stage symptoms of ovarian cancer may be recognizable and could be used to develop a symptom index for early disease.
|
Women in Sunnier Countries Have Lower Ovarian Cancer Rates
The risk of developing ovarian cancer is 60 percent lower among women living in areas of the world with high ultraviolet B radiation exposure.
|
Radiofreqency Ablation Useful In Treating Ovarian Cancer Metastasis
Treatment of ovarian cancer requires multi modality approaches including surgery and chemotherapy, but a small number of patients may benefit from radiofrequency ablation instead of repeated surgery
|
Viral Therapies That Fight Ovarian Cancer To Be Trialled Using PET Scanning
Viruses tailored to fight ovarian cancer can now be tested in clinical trials, thanks to new research.
|
Preventive Ovary Removal Linked to Early Death in Younger Women
If a woman under 45 has ovarian cancer or a benign disease in the ovaries that requires removal, however, compelling reason remains to remove the ovaries.
|
Fatty Spheres Loaded With siRNA Shrink Ovarian Cancer Tumors In Preclinical Trial
Nanoparticles slip through blood vessel pores to attack ovarian cancer tumor cells.
|
Chronic Stress Agitates Ovarian Cancer
Reducing stress slows ovarian cancer tumor growth.
|
Potential Ovarian Cancer Stem Cells
Cells may underlie ovarian cancer symptoms recurrence and resistance, suggest new treatment approaches.
|
Removal of Ovaries Decreases Risk of Certain Cancers for Women at High-Risk
Women with mutations in the BRCA1 or BRCA2 genes can significantly reduce their risk of certain types of cancer by having their ovaries removed.
|
Regular Paracetamol Use Could Reduce Ovarian Cancer Risk
Using paracetamol regularly could reduce the risk of ovarian cancer by almost a third.
|
Ovarian Cancer Responds To Aspirin Derivative With Chemo
As a first course of treatment, ovarian cancer typically is treated with surgery followed by a regimen of the chemotherapy drug cisplatin.
|
A Better Method of Detecting Ovarian Cancer
The pelvic examination can only occasionally detect ovarian cancer, generally when the disease is already in advanced stages.
|
Multimarker Assay for Ovarian Cancer Most Promising to Date
Research identified a combination of several biomarkers that could help detect ovarian cancer much earlier than it is currently being diagnosed.
|
Criteria to Detect Ovarian Cancer in Asymptomatic Postmenopausal Women
Accurate interpretation of test results could ultimately help to save the lives of postmenopausal women who do not present with symptoms but have ovarian cancer.
|
